The rising interest in GLP-1 agonists for diabetes has led to a question about application forms : skin-applied devices versus tablets . Usually , GLP-1 therapies were only available in pill form, but https://keithknoz229849.dailyhitblog.com/46578203/glp-1-transdermal-delivery-systems-vs-pills-what-best-for-the-patient